Liraglutide in combination with acitretin for severe recalcitrant psoriasis

British Journal of Dermatology

Volumn 169, Issue 1, 2013, Pages 230-231

  Reid, C T ^a   Tobin, A M ^a   Ahern, T ^a   O'Shea, D ^a   Kirby, B ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; EFALIZUMAB; ETANERCEPT; ETRETIN; FUMARIC ACID DERIVATIVE; LIRAGLUTIDE; METHOTREXATE; PSORALEN DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; KERATOLYTIC AGENT;

AMELANOTIC MELANOMA; DERMATOLOGY LIFE QUALITY INDEX; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; CASE REPORT; CHRONIC DISEASE; DRUG COMBINATION; MALE; MIDDLE AGED;

ACITRETIN; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PSORIASIS;

EID: 84879988423     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12380     Document Type: Letter

References (10)

1. Sadlier M, Lally A, Kirby B,. Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor alpha therapies: a case series. Br J Dermatol 2012; 167: 937-8.
2. Tobin AM, Hackett C, Rogers S, et al,. The effect of obesity on psoriasis. Br J Dermatol 2011; 165 (Suppl. 1): 10.
3. Hogan AE, Tobin AM, Ahern T, et al,. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia 2011; 54: 2745-54.
4. Ahern T, Tobin AM, Corrigan M, et al,. Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study. J Eur Acad Dermatol Venereol 2012 Jun 13 [Epub ahead of print].
5. Buysschaert M, Tennstedt D, Preumont V,. Improvement of psoriasis during exenatide treatment in a patient with diabetes. Diabetes Metab 2012; 38: 86-8.
6. Faurschou A, Knop FK, Thyssen JP, et al,. Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide. Acta Diabetol 2011 Dec 13 [Epub ahead of print].
7. Peternel S, Kastelan M,. Immunopathogenesis of psoriasis: focus on natural killer T cells. J Eur Acad Dermatol Venereol 2009; 23: 1123-7.
8. Tobin AM, Lynch L, Kirby B, O'Farrelly C,. Natural killer cells in psoriasis. J Innate Immun 2011; 3: 403-10.
9. Faurschou A, Zachariae C, Skov L, et al,. Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism? Med Hypotheses 2011; 77: 1098-101.
10. National Institute for Health and Clinical Excellence. Liraglutide for the treatment of type 2 diabetes mellitus. Available at: http://www.nice.org.uk/ nicemedia/live/13248/51259/51259.pdf (last accessed 3 April 2013).